Analysis
FDA cheerleads bivalent JAP Boosters as as research & ‘rebounds’ raise Efficacy Doubts [Video]
FDA cheerleads bivalent Boosters, Paxlovid as research and ‘rebounds’ raise Efficacy Doubts Vaccines chief may have been cut out of White House-Pfizer loop on early trial data for Omicron-targeting booster, recalling White House making original […]